Sign in

CIK 0001069530

  • Non-accelerated filer
  • Smaller reporting company

FILANA THERAPEUTICS, INC.

Sign in to watch
Ticker
FLNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911911336
Phone
+1 512-501-2444
Business address
6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
Former names
CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
  1. 4 Derivatives Options or other derivatives
  2. 4/A Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Other acquisition Chief Financial Officer acquired 4,346 shares (other)
  8. 4 Other acquisition Chief Operating Officer acquired 3,622 shares (other)
  9. 4 Grant or award CEO, Chairman of the Board acquired 45,000 shares (grant or award)
  10. 4 Grant or award Chief Financial Officer acquired 11,032 shares (grant or award)
  11. 4 Grant or award Chief Operating Officer acquired 10,000 shares (grant or award)
  12. 4 Other acquisition Chief Operating Officer acquired 596 shares (other)
  13. 4 Other acquisition Chief Financial Officer acquired 192 shares (other)
  14. 4 Open-market sale Chief Operating Officer sold 25,000 shares at $4.44 ($111,008)
  15. 4 Open-market sale 10% owner sold 382,000 shares at an average $4.59 ($1,754,072)
  16. 4 Open-market sale Chief Operating Officer sold 25,000 shares at an average $4.81 ($120,301)
  17. 4 Open-market sale Chief Operating Officer sold 25,000 shares at $4.89 ($122,125)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 13 of 30 · 591 filings